Does the Kampo medicine Goshajinkigan prevent neuropathy in breast cancer patients treated with docetaxel?
Concomitant administration of GJG is useful in preventing neuropathy in breast cancer patients treated with a DOC regimen.
Thus, Ad-36 E4 orf-1 is a novel inducer of rodent and human adipocyte differentiation process.